Naringin attenuates rat myocardial ischemia/reperfusion injury via PI3K/Akt pathway-mediated inhibition of apoptosis, oxidative stress and autophagy

Abstract

Naringin (NRG) has been reported to exert cardioprotective effects against multiple cardiovascular diseases, including lipopolysaccharide-induced and hyperglycemia-induced myocardial injury. However, the role of NRG in myocardial ischemia/reperfusion (I/R) injury remains unclear. In the present study, the PI3K/Akt pathway was investigated to evaluate the possible mechanisms underlying the roles of NRG in myocardial ischemia/reperfusion (I/R) injury. The levels of cardiac enzymes were measured by ELISA to evaluate the optimal dosage of NRG that could protect against myocardial I/R injury. Rats were administered 100 mg/kg of NRG and activities of myocardial enzymes, the level of cardiac apoptosis and inflammation, oxidant response, autophagy indicators and echocardiography were evaluated. The level of corresponding proteins was measured using western blotting. The results indicated that NRG elicited the best cardioprotective effects at a dose of 100 mg/kg by significantly reducing the levels of myocardial enzymes, apoptosis, inflammation, oxidative response and infarct size. Furthermore, NRG alleviated contractile dysfunction by increasing the left ventricular ejection fraction and fractional shortening. In addition, NRG markedly promoted the phosphorylation of Akt, while decreasing the level of autophagy indicator beclin-1 and the microtubule-associated protein 1B-light chain 3 (LC3B) II/ LC3BI ratio. However, PI3K/Akt inhibitor (LY294002) partially reduced the NRG induced phosphorylation of Akt and the reduction in beclin-1, along with the LC3BII/LC3BI ratio. The results of the present study demonstrated that NRG could attenuate myocardial I/R injury.

Introduction

Acute myocardial infarction (AMI) is a life-threatening disease characterized by high morbidity and mortality (1). Ischemia/reperfusion (I/R) injury is often accompanied by the restoration of occluded arteries, leading to excessive inflammation, oxidative stress and cardiomyocyte apoptosis (2,3). Furthermore, I/R-mediated myocardial damage increases the mortality of patients with AMI (4). Therefore, it is urgent to develop effective therapeutic strategies for the prevention of I/R injury.

Naringin (NRG), a citrus flavonoid, was initially extracted from pomelo peel (5). In traditional Chinese medicine, NRG is reported to exert protective effects against multiple cardiovascular diseases. Chen et al (6) demonstrated that NRG could alleviate anoxia/reoxygenation induced cardiomyocyte apoptosis by promoting nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear translocation in vitro. Jian et al (5) indicated that NRG was able to relieve doxorubicin-induced cardiotoxicity by suppressing myocardial apoptosis via the p38MAPK pathway. Additionally, NRG was observed to attenuate sepsis-associated cardiac dysfunction by inhibiting the inflammatory response and oxidative stress (7). Though these studies indicate that NRG may be useful as a therapeutic agent in the treatment of cardiovascular diseases, its effects on myocardial I/R injury require further investigation.

The PI3K/Akt signaling pathway is a conserved family of signal transduction pathway that participates in the modulation of multiple biological processes, including cell proliferation, oxidative response and cardiac apoptosis (8). Numerous studies have demonstrated that pharmacological activation of the PI3K/Akt pathway could effectively enhance the defensive ability of cardiomyocytes against I/R injury, as manifested by an increase in anti-inflammatory, anti-apoptotic and anti-oxidative capacity (9,10). In addition, the PI3K/Akt signaling pathway was reported to depress I/R-induced excessive autophagy thus attenuating I/R injury (11,12). A study by Rani et al (13) also suggested that the cardioprotective effects of NRG were closely related to the PI3K/Akt pathway.

In the present study whether NRG could alleviate myocardial I/R injury in vivo was investigated. In addition, the in-depth modulatory effect of NRG on the PI3K/Akt signaling cascade was examined.

Materials and methods

Animals

All procedures involving animals were conducted according to the Guide for the Care and Use of Laboratory Animals (NIH Publication no. 85-23, revised 1996) (14) and were approved by the Institutional Animal Care and Use Committee of Hubei University of Medicine. A total of 80 male Sprague-Dawley rats (weight 210-250 g; age, 7-8 weeks) were purchased from Hubei University of Medicine. The rats were acclimatized to the specific pathogen free conditions at a room temperature 24±2˚C, humidity of 55±5% on a 12-h light/dark cycle and were allowed free accesses to food and water.

I/R model and protocol for in vivo experiments

An I/R model was established as previously described (12). Briefly, rats were anesthetized by intraperitoneal injection of sodium thiopentone (70 mg/kg) and then mechanically ventilated with tracheal intubation (70 strokes/min). Subsequently, thoracotomy and pericardiotomy were performed at the left side in the three to four intercostal space to expose the heart. The left anterior descending (LAD) coronary artery was occluded using a 6-0 silk suture 2-3 mm below the left auricle. An obvious elevation in the ST segment was considered as successful establishment of ischemia. After 30 min of LAD occlusion, the artery was reperfused for 180 min. NRG (HPLC≥99%; Shanghai Winherb Medical S&T Development Co., Ltd.) was dissolved in normal saline (15) and continuously administrated by intraperitoneal injection for 1 week before I/R induction. LY294002 (PI3K/Akt inhibitor, 0.3 mg/kg; MedChemExpress) was given 30 min before I/R induction via caudal vein injection.

Rats were first randomly assigned to the following groups to determine the optimal dose of NRG administration: i) Sham group; ii) I/R group; iii) NRG (25 mg/kg/day) + I/R group (NRG25 + I/R); iv) NRG (50 mg/kg/day) + I/R group (NRG50 + I/R); and v) NRG (100 mg/kg/day) + I/R group (NRG100 + I/R). The 100 mg/kg dose of NRG was proven to exert the best cardioprotective effects and subsequently the rats were randomly assigned into the following groups to evaluate the functions of NRG in myocardial I/R injury: i) Sham group; ii) I/R group; iii) NRG100 + I/R group; and iv) NRG100 + I/R + LY294002 group (NRG100 + I/R + LY).

Evaluation of myocardial injury

After 180 min of reperfusion, blood specimens were obtained and centrifuged 1,000 x g for 15 min at a room temperature in preparation for the measurement of creatine kinase (CK), lactate dehydrogenase (LDH) and cardiac troponin I (cTnI). Creatine kinase isoenzyme Assay kit (cat. no. E006; Nanjing Jiancheng Bioengineering Institute), lactate dehydrogenase assay kit (cat. no. A020-1; Nanjing Jiancheng Bioengineering Institute) and Troponin Assay kit (no. E019-1; Nanjing Jiancheng Bioengineering Institute) were used for the analyses according to the manufacturer's instructions.

Assessment of infarct size

2,3,5-triphenyltetrazolium chloride (TTC; Sigma-Aldrich; Merck KGaA) staining was applied to evaluate the infarcted size as previously described (8). Hearts were harvested and frozen at -80˚C after 180 min of reperfusion. Subsequently, hearts were cut from the apex to the base, these slices were then incubated with 1% TTC for 20 min at 37˚C . The infarct area (white) were evaluated using Image Pro Plus 6.0 (Media Cybernetics, Inc.).

Assessment of oxidative stress

Blood specimens were obtained for the measurement of malondialdehyde (MDA) and superoxide dismutase (SOD) using Malondialdehyde assay kit (cat. no. A003-1; Nanjing Jiancheng Bioengineering Institute) and Superoxide Dismutase assay kit (cat. no. A001-3; Nanjing Jiancheng Bioengineering Institute) according to the manufacturer's instructions.

Detection of myocardial apoptosis

The degree of myocardial apoptosis was assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining using the In Situ Cell Death Detection kit (cat. no. 11684817910; Roche Diagnostics GmBH) in accordance with the manufacturer's instructions. Cardiomyocytes with marked nuclear labeling were considered TUNEL-positive using a fluorescence microscope. A total of 3 fields (magnification, x200) were randomly selected per heart to determine apoptosis index (AI) using image-pro 5.0 (Media Cybernetics, Inc.). The formula for calculating AI was as follows, AI=number of apoptotic cells/total number of cells counted.

Analysis of the inflammatory response

The levels of interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) released from myocardium were evaluated using Interleukin-1β Assay kit (cat. no. H002; Nanjing Jiancheng Bioengineering Institute), Interleukin-6 Assay kit (cat. no. H007; Nanjing Jiancheng Bioengineering Institute) and Tumor Necrosis Factor-α Assay kit (cat. no. H052; Nanjing Jiancheng Bioengineering Institute) in accordance with the manufacturer's instructions.

Histopathological examination

Heart samples were fixed in paraffin and cut into transverse sections (5-µm thick) before staining with hematoxylin and eosin (H&E) (16). The stained slices were then analyzed under a light microscope (model no. BX51; Olympus Corporation). A total of 5 fields (magnification, x200) were randomly chosen from each group and scored in a blinded manner by 2 individuals (Department of Cardiology, Suizhou Hospital) according to the following criteria as previously described (17): 0, no abnormality was observed; 0.5, with minor lesions; 1.0, with sparse lesions; 1.5, with intermediate lesions; and 2.0, extensive hemorrhage and leukocytic infiltration.

Echocardiography

Cardiac performance was analyzed by non-invasive echocardiography after a 180 min period of reperfusion using an ultrasound Doppler imaging system [Vinno Technology (Suzhou) Co., Ltd.]. The heart rate (HR), left ventricular internal dimension systole (LVIDs), left ventricular internal dimension diastole (LVIDd), ejection fraction (EF) and fractional shortening (FS) were obtained as previously described (18).

Western blotting

Myocardial tissue was immediately harvested and stored in liquid nitrogen 180 min after reperfusion. Western blotting was carried out using a previously described method (19). Primary antibodies applied for western blotting were as follows: Bcl-2 (1:2,000; cat. no. ab59348; Abcam); p-Akt (1:1,000, cat. no. 4060, Cell Signaling Technology, USA); Akt (1:3000, cat. no. 4691, Cell Signaling Technology, Inc.); GADH (1:10,000; cat. no. ab37168; Abcam); cleaved caspase3 (1: 1,000; cat. no. AF7022, Affinity Biosciences Ltd.); microtubule-associated protein 1B-light chain 3 (LC3BI; 1:1,000, ; cat. no. 4599; Cell Signaling Technology, Inc.); LC3BII (1:1,000; cat. no. 3868; Cell Signaling Technology, Inc.); beclin-1 (1:2,000; cat. no. 3495; Cell Signaling Technology, Inc.) and caspase 3 (1:1,000; cat. no. ab44976, Abcam).

Secondary antibody was horseradish peroxidase (HRP) goat anti-Rabbit (1:10,000; cat. no. AS1107; Wuhan Aspen Biotechnology Co. Ltd.)

Statistical analysis

Continuous variables are presented as the mean ± standard deviation (SD) and were analyzed using SPSS 18.0 (SPSS, Inc.). One-way analysis of variance (ANOVA) followed by Tukey's post hoc test was used for multiple comparisons among groups. P<0.05 was defined as statistically significant.

Results

NRG administration alleviates myocardial I/R injury

The level of myocardial enzymes can reflect the degree of I/R-induced myocardial damage (20). As demonstrated in Fig. 1A-C, I/R significantly promoted the release of the cardiac enzymes CK-MB, cTnI and LDH in comparison with sham surgery, while pretreatment with NRG decreased the levels of these myocardial enzymes released following I/R. NRG pretreatment at a dose of 100 mg/kg displayed the highest cardioprotective effect against I/R injury, as indicated by the significant reduction in the levels of creatine kinase myocardial band (CK-MB), cTnI and LDH as compared to I/R. Therefore, the optimal dose of NRG was considered to be 100 mg/kg. The results also indicated that pretreatment with LY294002, a PI3K/Akt inhibitor, reversed the cardioprotective effects of NRG (Fig. 1D-F). The myocardial structure in the I/R group was altered in comparison with that in the sham animals with a disorderly arrangement of cardiomyocytes, necrosis and hemorrhage and relatively high damage scores (Fig. 1G-H). However, I/R-induced myocardial structural changes were significantly reduced by NRG treatment with a lower damage score, while LY294002 abolished the effects of NRG.

Figure 1.

NRG pretreatment attenuates cardiac I/R injury. Serum levels of (A) CK-MB, (B) cTnI and (C) LDH (n=5) after I/R and following pretreatment with different NRG doses. The expression levels of (D) CK-MB, (E) cTnI and (F) LDH (n=5) after I/R with use of a PI3K/Akt inhibitor. (G) Representative images of heart tissues following hematoxylin and eosin staining. (H) Damage score (n=5). NRG, naringin; I/R, ischemia reperfusion; CK-MB, creatine kinase myocardial band; cTn1, cardiac troponin 1; LDH, lactate dehydrogenase; LY, PI3K/Akt inhibitor LY294002; NRG25, 25 mg/kg naringin; NRG50, 50 mg/kg naringin; NRG100, 100 mg/kg naringin. ^aP<0.05 vs. sham group; ^bP<0.05 vs. I/R group; ^cP<0.05 vs. I/R group; ^dP<0.05 vs. NRG50 + I/R group.

Anti-inflammatory and anti-oxidative effects of NRG

The results of the present study suggested that I/R triggered an inflammatory response by increasing the release of inflammatory factors TNF-α, IL-1β and IL-6 (Fig. 2A-C). NRG pretreatment significantly inhibited the release of inflammatory factors accelerated by I/R. However, LY294002 partially abrogated the effects of NRG.

Figure 2.

NRG pretreatment alleviates I/R-accelerated inflammatory reactions, oxidative stress and infarct size. The expression levels of (A) TNF-α, (B) IL-1β and (C) IL-6 (n=5); (D) The level of MDA (n=5). (E) The level of SOD (n=5). (F) Representative images of 2,3,5-triphenyltetrazolium chloride stain. (G) Quantitative analysis of infarct size (n=3). NRG, naringin; I/R, ischemia reperfusion; TNF-α, tumor necrosis factor-α; IL, interleukin; MDA, malondialdehyde; SOD, superoxide dismutase; NRG100, 100 mg/kg naringin; LY, PI3K/Akt inhibitor LY294002. ^aP<0.05 vs. sham group; ^bP<0.05 vs. I/R group; ^cP<0.05 vs. NRG100 + I/R group.

A significant reduction in SOD activity and MDA concentration was observed in the NRG + I/R group in comparison with I/R (Fig. 2D-E). However, the effects of NRG were abolished by LY294002. These finding demonstrated that NRG could mitigate I/R-induced oxidative stress and inflammatory signaling.

Assessment of infarct size

As demonstrated in Fig. 2F and G, the infarct size in the I/R group was significantly increased in comparison with the sham group. However, NRG pretreatment notably reduced the infarct size and these effects were abrogated by LY294002.

Effects of NRG on heart function

As displayed in Table I, I/R significantly aggravated cardiac dysfunction by enlarging LVIDs and impairing EF and FS. However, NRG pretreatment markedly improved cardiac performance by narrowing LVIDs while promoting FS. The administration of the PI3K/Akt inhibitor LY294002, abrogated the effects of NRG.

Table I.

Effects of NRG on cardiac performance.

Group	HR (beats/min)	LVIDs (mm)	LVIDd (mm)	EF (%)	FS (%)
Sham	442.32±16.32	2.41±0.31	4.98±0.18	84.62±3.21	59.48±2.69
I/R	429.85±15.75	3.24±0.36a	5.02±0.21	55.36±4.23a	32.25±1.38a
NRG100 + I/R	432.48±17.63	2.95±0.25b	5.07±0.23	66.31±2.41a	37.62±1.57a
NRG100 + I/R +LY	425.17±19.32	3.19±0.32c	5.04±0.20	53.36±4.06a	31.24±1.45a

HR, heart rate; LVIDs, left ventricular internal dimension systole; LVIDd, left ventricular internal dimension diastole; EF, ejection fraction; FS, fractional shortening.

^aP<0.05 vs. sham group;

^bP<0.05 vs. I/R group;

^cP<0.05 vs. NRG+I/R group. Data are presentedas the mean ± standard deviation.

NRG pretreatment reduces myocardial apoptosis

The present results showed that the AI (Fig. 3A-B) and the expression of cleaved caspase3 were dramatically increased in the I/R group, while the level of Bcl-2 was notably decreased in comparison with the sham group (Fig. 4A-D). NRG pretreatment markedly reduced AI and cleaved caspase3 expression and significantly increased the level of Bcl-2 in comparison with the I/R group. These results suggested that NRG could suppress I/R induced myocardial apoptosis. However, LY294002 partially abolished the cardioprotective effects of NRG.

Figure 3.

NRG pretreatment suppresses I/R-induced myocardial apoptosis. (A) Representative images of TUNEL stain; (B) Apoptosis index (n=5). NRG, naringin; I/R, ischemia reperfusion; LY, PI3K/Akt inhibitor LY294002; NRG100, 100 mg/kg naringin. ^aP<0.05 vs. sham group; ^bP<0.05 vs. I/R group; ^cP<0.05 vs. NRG100 + I/R group.

Figure 4.

NRG pretreatment represses myocardial autophagy through PI3K/Akt signaling cascades. (A) Representative images of western blotting. Quantitative analysis of the (B) Bax, and (C) Bcl levels and the (D) cleaved caspase: caspase 3 and (E) p-Akt: Akt ratio and the (F) beclin-1 and (G) LC3BII: LC3BI ratio (n=3). NRG, naringin; I/R, ischemia reperfusion; LY, PI3K/Akt inhibitor LY294002; NRG100, 100 mg/kg naringin; p-Akt, phosphorylated Akt; LC3B, microtubule-associated protein 1B-light chain 3. ^aP<0.05 vs. sham group; ^bP<0.05 vs. I/R group; ^cP<0.05 vs. NRG100 + I/R group.

NRG pretreatment activates the PI3K/Akt signaling pathway

As shown in Fig. 4A and E, I/R injury significantly reduced the phosphorylation of Akt as compared to sham group. However, NRG pretreatment remarkably promoted the phosphorylation of Akt. Administration of LY294002 abrogated the effect of NRG, indicating that NRG could activate the PI3K/Akt signaling pathway.

NRG pretreatment inhibits myocardial autophagy

Compared with the sham group, I/R significantly increased the expression of Beclin-1 and the LC3BII/LC3BI ratio (Fig. 4A, F and G). However, I/R-induced increases in Benlin-1 expression and LC3BII/LC3BI ratio were suppressed by NRG pretreatment, suggesting that NRG could inhibit I/R-promoted myocardial autophagy. LY294002 partially abolished NRG-mediated anti-autophagy effect against I/R.

Discussion

The results of the present study demonstrated that NRG pretreatment could alleviate I/R-induced myocardial injury and cardiac dysfunction by suppressing apoptosis, the inflammatory response and oxidative stress. I/R-promoted myocardial autophagy was also inhibited by NRG pretreatment. Furthermore, the cardioprotective effects of NRG may be closely related to the activation of the PI3K/Akt signaling cascades.

NRG is a pharmacologically active constituent of tomentose pummelo peel, chemically known as 4,5,7-trihydroxy-flavonone-7-rhamnogglucoside (5). NRG has been reported to have multiple cardioprotective effects. Rajadurai and Prince (21) demonstrated that NRG protected against isoproterenol-induced myocardial infarction by increasing the anti-oxidative capacity of the myocardium, as evidenced by the enhanced levels of SOD, glutathione s-transferase and glutathione peroxidase. Similar results were reported by Li et al (22) who revealed that NRG could suppress TNF-α-induced oxidative stress and the inflammatory response via the PI3K/Akt pathway. I/R injury could significantly promote oxidative stress thus reduces the activity of SOD (23,24). It is known that Akt signaling plays a crucial role in the modulation of multiple biological processes in cardiovascular diseases. Numerous studies have demonstrated that pharmacological activation of PI3K/Akt could effectively enhance the activities of SOD against I/R injury (20,25). Yang et al (26) demonstrated that PI3K/Akt cascades could facilitate Nrf2 nuclear translocation and therefore promote SOD activity in cardiomyocytes after hypoxia-reoxygenation procedures. Sun et al (27) found that PI3K/Akt signaling could notably activates the endothelial nitric oxide synthase pathway to enhance the anti-oxidative capacity of cardiomyocytes against I/R injury.

Myocardial I/R injury occurs with the restoration of blood flow to the occluded coronary artery (7). Myocardial apoptosis, the inflammatory response, oxidative stress and autophagy constitute crucial parts in the pathophysiological procedure of I/R injury (7). Rani et al (13). demonstrated that NRG significantly attenuated myocardial I/R injury by diminishing cardiac apoptosis as well as oxidative stress. A study by Chen et al (6) reported that NRG pretreatment mitigated anoxia/reoxygenation-induced apoptosis via the Nrf2 pathway in vitro. Consistent with these findings, the results of the present study also showed that NRG exerted cardioprotective effects against I/R injury via a reduction in the levels of pro-apoptotic proteins and oxidative stress, while promoting the expression of anti-apoptotic protein Bcl-2.

Myocardial I/R injury is also characterized by an excessive level of inflammation response (28). Inflammatory mediators such as IL-1β, IL-6 and TNF-α could significantly contribute to the myocardial dysfunction and structural alterations in the failing heart (29). Additionally, TNF-α could further exert deleterious effects on myocardial I/R injury by promoting oxidative stress and the inflammatory response (30). Tong et al (20) demonstrated that I/R markedly increased the release of inflammatory cytokines, while the activation of the PI3K/Akt pathway could significantly repress I/R-mediated inflammation via down-regulation of high mobility group box protein. In sepsis-associated myocarditis, NRG also displayed anti-inflammatory effects (7). The above evidence supported the hypothesis that NRG could attenuate I/R injury via effectively inhibiting inflammatory response.

Autophagy is a dynamic process in which cellular waste is encapsulated into double membrane vesicles and then transported to lysosomes for degradation (31). A normal state of autophagy is necessary for the renewal of organelles (32). The signaling pathways involved in autophagy have been extensively studied and the PI3K/Akt pathway is widely recognized as a crucial mediator in the regulation of autophagy (33,34). Li et al (35) demonstrated that pharmacological activation of PI3K/Akt could effectively suppress hypoxia/reoxygenation-induced autophagy in neonatal rats by targeting rapamycin. Ye et al (12) also confirmed that phosphorylated Akt could attenuate I/R-promoted myocardial autophagy via secretion of basic fibroblast growth factors. LC3BII/LC3BI ratio and Beclin-1 are representative autophagy markers, and their levels can directly reflect the degree of autophagy (36,37). Consistent with the aforementioned studies, the results of the present study indicated that I/R injury significantly promoted the expression of Beclin-1 and LC3BII/LC3BI ratio, while NRG pretreatment markedly reversed the up-regulated Beclin-1 and LC3BII/LC3BI ratio. However, these cardioprotective effects of NRG were partially abolished by the PI3K/Akt inhibitor LY294002. These results suggested that NRG may suppress I/R-induced myocardial autophagy by facilitating the PI3K/Akt signaling pathway.

There are a number of limitations to the present study. Specific PI3K/Akt inhibitors, such as Dactolisib or IC87114, might better have illustrated the cardioprotective role of NRG against I/R injury and an LY treatment alone group could also have aided the interpretation of the results.

In summary, the results of the present study indicated that NRG alleviated myocardial I/R injury via inhibition of cardiac apoptosis, inflammatory reactions and oxidative stress. In addition, NRG pretreatment also attenuated I/R-induced autophagy. The present data also suggested that such cardioprotective effects of NRG could be ascribed to the activation of the PI3K/Akt pathway. Furthermore, short-term NRG pretreatment may be a novel therapeutic strategy for the prevention of I/R injury in AMI patients.

Funding Statement

Funding: The present study was supported by a grant from the Natural Science Foundation of Hubei Province of China (grant no. 2015CFB223).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

FL and ZZ were responsible for conceiving the study, performing the analysis and experiments and drafting the manuscript. JQ analyzed the data. CC and WY also performed the experiments. NW was involved in drafting the manuscript performing and designing the experiments as well as revising it for important intellectual content. FL and NW confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.

Ethics approval and consent participate

Animal experiments were approved by the Institutional Animal Care and Use Committee of Hubei University of Medicine.

Patient consent for publication

Not applicable.

Competing interest

The authors declare that they have no competing interests.